Zymfentra
Active Ingredient(s): InfliximabFDA Approved: * October 20, 2023
Pharm Company: * CELLTRION
Category: Immunosuppressive
Infliximab, a chimeric monoclonal antibody, sold under the brand name Remicade among others, is a medication used to treat a number of autoimmune diseases. This includes Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriasis, psoriatic arthritis, and Behçet's disease.[2] It is given by slow injection into a vein, typically at six- to eight-week intervals.[2] Common side effects include infections, acute infusion reacti... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.